Expression array analysis of the hepatocyte growth factor invasive program (Q38847534)

7 September 2017

title

Expression array analysis of the hepatocyte growth factor invasive program (English)

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Fabiola Cecchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Chih-Jian Lih

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Young H Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

William Walsh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Paul M Williams

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

language of work or name

1 reference

1 August 2015

1 reference

Clinical & Experimental Metastasis

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

page(s)

659-676

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

Hepatocyte growth factor twenty years on: Much more than a growth factor

15 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Invasive growth: a MET-driven genetic programme for cancer and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

From Tpr-Met to Met, tumorigenesis and tubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Identification of a Competitive HGF Antagonist Encoded by an Alternative Transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

A new crystal form of the NK1 splice variant of HGF/SF demonstrates extensive hinge movement and suggests that the NK1 dimer originates by domain swapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Structural basis of hepatocyte growth factor/scatter factor and MET signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Soluble c-Met receptors inhibit phosphorylation of c-Met and growth of hepatocyte growth factor: c-Met-dependent tumors in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

IGFBP-3 is a metastasis suppression gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Insulin-like growth factor binding protein-3 inhibits migration of endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Multi-faceted roles for CXC-chemokines in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

A CXCL1 paracrine network links cancer chemoresistance and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Frequent Gene Products and Molecular Pathways Altered in Prostate Cancer- and Metastasis-Initiating Cells and Their Progenies and Novel Promising Multitargeted Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The role of inflammation in the pathogenesis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Dose dependent activation of retinoic acid-inducible gene-I promotes both proliferation and apoptosis signals in human head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Integrative analysis of prostate cancer aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Heat shock proteins HSP70 and MRJ cooperatively regulate cell adhesion and migration through urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Heat shock proteins in cancer: chaperones of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Reciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The Deubiquitinating Enzyme USP8 Promotes Trafficking and Degradation of the Chemokine Receptor 4 at the Sorting Endosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Asparagine synthetase: regulation by cell stress and involvement in tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

NOV promoted the growth and migration of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Extracellular matrix components in breast cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The transcription factor SPDEF suppresses prostate tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The apparent uPA/PAI-1 paradox in cancer: more than meets the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Knockdown of TFPI-2 promotes migration and invasion of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Functional characterization of E- and P-cadherin in invasive breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

A transgenic mouse model for early prostate metastasis to lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

PTPmu suppresses glioma cell migration and dispersal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Integrin signalling adaptors: not only figurants in the cancer story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

A Trio-Rac1-Pak1 signalling axis drives invadopodia disassembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Functional evidence implicating S100P in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Transcriptional regulation and functional implication of S100P in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Joining S100 proteins and migration: for better or for worse, in sickness and in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Activation of Rap1 promotes prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Actin binding proteins: their ups and downs in metastatic life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The RUNX family in breast cancer: relationships with estrogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The death-inducer obliterator 1 (Dido1) gene regulates embryonic stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Most random gene expression signatures are significantly associated with breast cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion growth of digestive organs in zebrafish.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

PARI overexpression promotes genomic instability and pancreatic tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

The mutational landscape of lethal castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

em E2 em A basic helix-loop-helix transcription factors in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9735-0

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer

21 January 2018

1 reference

12 December 2020

Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis

1 reference

12 December 2020

SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model

1 reference

12 December 2020

In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrate

1 reference

12 December 2020

Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results.

1 reference

12 December 2020

Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding

1 reference

12 December 2020

E2A basic helix-loop-helix transcription factors in human leukemia

1 reference

12 December 2020

Principles of liver regeneration and growth homeostasis

1 reference

12 December 2020

Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins

1 reference

12 December 2020

The roles of CD73 in cancer

1 reference

12 December 2020

PRL-3 and PRL-1 promote cell migration, invasion, and metastasis

1 reference

12 December 2020

Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance

1 reference

12 December 2020

Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior

1 reference

12 December 2020

CXCR3, a double-edged sword in tumor progression and angiogenesis

1 reference

12 December 2020

10.1007/S10585-015-9735-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 June 2020

1011691595

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231668%20AND%20SRC:MED&resulttype=core&format=json